An abridged ®ve-item version of the 15-item International Index of Erectile Function (IIEF) was developed (IIEF-5) to diagnose the presence and severity of erectile dysfunction (ED). The ®ve items selected were based on ability to identify the presence or absence of ED and on adherence to the National Institute of Health's de®nition of ED. These items focused on erectile function and intercourse satisfaction. For 1152 men (1036 with ED, 116 controls) analyzed, a receiver operating characteristic curve indicated that the IIEF-5 is an excellent diagnostic test. Based on equal misclassi®cation rates of ED and no ED, a cutoff score of 21 (range of scores, 5±25) discriminated best (sensitivity 0.98, speci®city 0.88). ED was classi®ed into ®ve severity levels, ranging from none (22±25) through severe (5±7). Substantial agreement existed between the predicted and`true' ED classes (weighted kappa 0.82). These data suggest that the IIEF-5 possesses favorable properties for detecting the presence and severity of ED.
Introduction
Erectile dysfunction (ED) affects millions of men. The prevalence of ED depends on the population studied and the de®nition and methods used. 1 Because of this, estimated prevalence rates of ED have varied considerably and have included, for example, 52% from a study in the United States, 2 32% from a study in the United Kingdom, 3 26% from a study in Japan, 4 and 19% from a study in Denmark. 5 Despite considerable variation in the populations studied and the methods used, these reports indicate that ED bears a signi®cant correlation with age and a lower quality of life.
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The International Index of Erectile Function (IIEF), which consists of 15 items and 5 domains, is a psychometrically valid and reliable instrument that was developed through consultations with an international panel of experts for use in determining ef®cacy of treatment in controlled clinical trials. 9 The IIEF has high sensitivity and speci®city for detecting real treatment effects or the lack of treatment effects in patients with ED of broadspectrum etiology. 9 There is a need for a simple patient-administered diagnostic tool of ED for easy use by physicians in clinical settings. 10 The original IIEF instrument was designed speci®cally for use in clinical trials and is not well suited for use as a simple of®ce screening measure. One way to address this need is to investigate an abbreviated version of the IIEF. Erectile dysfunction is a self-reported condition, and there are no objective diagnostic tests available to physicians for con®rmation of the condition, making it dif®cult for physicians to make an accurate diagnosis. Consequently, a need exists for an easy-to-use clinical instrument for the detection of ED that can supplement physical examination and patient history in clinical settings and that can increase the likelihood of a correct diagnosis for men with or without ED.
In the design of an abbreviated questionnaire, a two-thirds reduction in the number of IIEF items, from 15 to 5, was chosen in advance, emanating from discussions with experts and focus groups. The National Institutes of Health (NIH) Consensus Panel has de®ned erectile dysfunction (ED) as the inability to achieve and/or maintain penile erection suf®cient for satisfactory sexual performance. 10 Although several international de®nitions of ED exist, we anchored the ®ve items for inclusion based on the NIH de®nition as it was derived from consensus of a large group of experts. Furthermore, such a diagnostic instrument for ED should discriminate well between men with and without ED and accurately re¯ect grades of ED severity. 10 This report describes the construction and evaluation of an abbreviated version of the IIEF, designated as the IIEF-5, as a diagnostic tool for ED and provides data supporting its use as a diagnostically valid instrument in clinical settings worldwide.
Methods

Subjects and studies
Men with clinically diagnosed ED were enrolled in four double-blind, placebo-controlled Phase III multicenter clinical trials investigating the safety and ef®cacy of VIAGRA1 (sildena®l citrate). The inclusion criteria for these trials required that patients with ED be at least 18 years old, be in a stable relationship with a female partner for at least the past six months, and have a clinical diagnosis of ED for a minimum of six months. Documented evidence of ED included a medical history of at least six months duration, physician records, and objective testing where available. Patients with ED of broad-spectrum etiology (organic, psychogenic, or mixed organic±psychogenic) were included. Patients with ED were excluded if they had penile anatomical disorders impairing erectile function, major medical illnesses (e.g uncontrolled diabetes or severe renal, hepatic or cardiovascular diseases), major psychiatric disorders, or a history of alcohol or drug abuse. A control group of men without a history of ED was recruited from volunteers at an outpatient community health center. The responses in the studies were from patients in the United States and the United Kingdom.
Selecting the ®ve items
The initial analyses performed for selecting the ®ve items of the IIEF-5 included data from all men in the Phase III trials and all control men who completed the 15 items of the IIEF questionnaire and who had sexual activity or attempted sexual intercourse within the four-week period before completing the questionnaire. This resulted in a total of 1047 men (932 with ED, 115 controls). Analyses of data from patients with ED were restricted to baseline data obtained during enrollment into the clinical trials (that is, before randomization to study drug). Each IIEF item is scored on a ®ve-point ordinal scale where lower values represent poorer sexual function. Thus, a response of 1 for a question was considered the least functional, whereas a response of 5 was considered the most functional.
The statistical program Classi®cation and Regression Trees (CART) 11, 12 was used to arrive at a diagnostically optimal set of ®ve items by simultaneously calculating and ranking the relative importance of the 15 items of the IIEF from a multivariate framework in terms of their ability to explicitly discriminate between men with and without ED. The score of each item in the chosen classi®cation tree was summed and scaled relative to the item that best discriminated between ED and no ED. The most important discriminating item received a score of 100 and the least important a score of 0. The ®ve items selected for the IIEF-5 had to clearly discriminate between study subjects with and without ED, as well as address the NIH de®nition of ED. Possible scores for the IIEF-5 range from 5 to 25.
Evaluating the ®ve items for discrimination
The diagnostic evaluation of the ®ve items chosen for the IIEF-5 included scores from all 1047 subjects who had completed all 15 items of the IIEF. It also included scores from a second cohort of men who had not completed all 15 items but who had provided responses to the ®ve items selected for inclusion in the IIEF-5. Four complementary types of statistical analyses were applied to evaluate the ability of the IIEF-5 to predict whether or not a subject had ED.
First, a receiver operating characteristic (ROC) curve was created in which the true-positive rate and the false-positive rate were paired across all potential cutoff points that distinguished between men with and without ED. 13 In the ROC curve, the true-positive rate (sensitivity) was the proportion of men with ED that the IIEF-5 correctly predicted as having ED; the higher the rate, the better the test. The false-positive rate (1 7 speci®city) was the proportion of men without ED that the IIEF-5 incorrectly predicted as having ED; the lower the rate, the better the test. The true-negative rate (speci®city) was therefore the proportion of men without ED that the IIEF-5 correctly classi®ed as having no ED. Therefore, a desired cutoff score should have a high true-positive rate and a low falsepositive rate in partitioning men with ED from men without ED. The ROC curve was determined by comparing a subject's known diagnosis (ED, no ED) with the prediction based on each of the 21 candidate cutoff scores on the IIEF-5 (that is, scores of 5±25). Subjects were retrospectively classi®ed as 14 and was used to further assess how well IIEF-5 scores could predict and relate to the presence or absence of clinical diagnosed ED.
Third, in determining the optimal cutoff score, the CART algorithm 11, 12 was used to evaluate the binary split of ED vs no ED for each of the 21 possible cutoff points (5±25) on the IIEF-5. Each cutoff point was evaluated on the basis of a goodness-of-split criterion as measured by the Gini diversity (impurity) index. 11, 12 The optimal cutoff resulted in the lowest Gini value and the least variability in the actual status of men categorized by CART as having ED or not having ED. The optimal cutoff was based on the assumption, consistent with the literature, 6 that a reasonable estimate of the prevalence rate of minimal-to-complete ED is about 50% in a clinical population of adult men. In CART, this is equivalent to having the error of misclassifying men with ED be equivalent to, or as serious as, the error of misclassifying men without ED.
Fourth, a cross-validation analysis with CART was undertaken to determine the stability of the binary split (ED vs no ED) for the optimal cutoff score by developing calibration rules for subsamples containing 90% of the subjects and testing these calibration rules on the other 10% of subjects. The CART algorithm analyzed a total of ten separate subsamples, each with a different 10% of the data used as a test sample, and inspected the classi®ca-tions for consistency. Cross-validated results were generated as the best estimates that would occur if the selected classi®cation tree was applied to new, fresh data. These cross-validation results were compared with the sample results from the tree applied to all of the sample data to determine the robustness of the evaluation.
For the cross-validated results and the sample results, the sensitivity and speci®city were then used to calculate the predicted value positive and the predicted value negative of the IIEF-5. 13 The predicted value positive was the proportion of men with actual ED among men classi®ed as having ED based on their IIEF-5 scores. The predicted value negative was the proportion of men without ED among men classi®ed as not having ED based on their IIEF-5 scores. These predicted values depended on the prevalence rate of ED in a clinical population, assumed to be about 50%. 6 Exact 95% con®dence intervals for sensitivity, speci®city, predicted value positive, and predicted value negative were calculated using StatXact. 15 For the cross-validated and sample results, the kappa coef®cient and its 95% con®dence intervals were also calculated 15 to provide a measure of overall agreement, beyond chance, between the actual diagnosis and the diagnosis predicted from the IIEF-5 scores.
Evaluating the ®ve items for classifying degrees of erectile dysfunction
Men were not asked to self-rate their severity of ED, nor did clinicians rate the overall severity of ED of their patients. Because there was no independent criterion for severity of ED, we created a surrogate measure for it by choosing the IIEF item not in the IIEF-5 that best discriminated ED from no ED and that conformed to the NIH de®nition of ED. After determining this surrogate item, we established a gradient of severity for ED by adopting the following 3-tier approach:
Step 1. The clinical outcome (ED, no ED) was expressed as a function of the ®ve ordinal values on the surrogate item for ED severity to determine, using CART, which categories of this item belong to men with ED and which belong to men without ED.
Step 2. For men with actual ED, categories of the item that belonged to ED (from Step 1), which were analyzed as ordinal responses, were expressed as a function of IIEF-5 scores to determine, using CART, a range of IIEF-5 scores that corresponded to each category of the item. The range of IIEF-5 scores for no ED was determined beforehand by those scores exceeding the optimal cutoff point from the analysis that discriminated between ED and no ED (see previous section).
Step 3. Using a general linear model and Scheffe's multiple comparisons test in SAS, 14 we tested whether the mean IIEF-5 score of a given severity category of ED signi®cantly differed from each of the other categories.
The weighted kappa coef®cient 15 was calculated to provide an indication of overall agreement, beyond chance, between the`true' classi®cation of ED severity (from categories on the surrogate item for ED severity) and the predicted classi®cation of ED severity (from the IIEF-5 scores). In addition, the correlation between these two sets of classi®cations were computed using the Spearman rank-order correlation and the Kendall rank-order (tau-b) correlation; exact 95% con®dence intervals of these correlations were calculated. 15 
Results
Selecting the ®ve items
Selecting the ®ve items for inclusion in the IIEF-5 was accomplished by reviewing the 1047 responses of 932 men with ED and 115 men without ED who Abridged version of IIEF-5 RC Rosen et al completed the full-length, 15-item IIEF questionnaire. For these men, the average age in the ED group (54.1 y) and the control group (56.1 y) was similar. For subjects with ED, the average duration was 4.2 y and their etiologies were 49.1% organic, 22.0% psychogenic, 28.6% mixed, and 0.3% other. Table 1 shows the rank in relative importance of items on the 15-item IIEF questionnaire in discriminating between men with and without ED.
As shown in Table 1 , the ®rst four discriminatorsÐmaintenance ability (Item 5), erection con®dence (Item 15), maintenance frequency (Item 4), and erection ®rmness (Item 2)Ðconform to the NIH de®nition of ED. The`satisfactory sexual performance' component of the NIH de®nition was not explicitly characterized by the top ®ve items with the greatest discriminatory power. Therefore, Item 3, the ®fth best discriminator, was replaced with Item 7 on sexual intercourse satisfaction, the next best discriminator. Hence, the IIEF-5 consists of Items 5, 15, 4, 2, and 7 from the IIEF. Table 2 presents the components of the IIEF-5 questionnaire. Items have been rephrased to address the past six months of sexual activity, instead of the past four weeks, to conform to the NIH's current reference period for establishing a diagnosis of ED.
Evaluating the ®ve items
After the items on the IIEF-5 were chosen, an evaluation of the questionnaire was performed based on all men with completed scores on the IIEF-5: 1036 men had ED and 116 men did not have ED. These 1152 subjects came from the same set of clinical studies from which the initial 1047 subjects were selected and included an additional 105 subjects from these studies who had provided responses to IIEF-5 items but did not respond to at least one of the nine remaining items on the 15-item IIEF questionnaire. Ten men with ED who reported no sexual activity during the designated period were not included in the analysis. The average IIEF-5 score for men clinically diagnosed with ED (mean AE s.d.: 11.1 AE 4.7, range 5±25) was signi®-cantly lower (P`0.0001) than the average IIEF-5 Figure 1 depicts the ROC curve for the IIEF-5. This curve, which lies predominantly far upward and to the left, shows relatively high true-positive rates and low false-positive rates. The estimated area under the ROC curve was 0.97. Hence, from a randomly selected pair of men, one with ED and one without ED, there was about a 97% chance of correctly identifying the man with ED and the man without ED based on their IIEF-5 scores alone.
The ROC curve can help determine desired cutoff points on the IIEF-5 for predicting a diagnosis of ED. As shown in Table 3 , integer scores ranging from 14 to 22 on the IIEF-5 were candidate cutoff points (based on their sensitivity and speci®city being at least 0.75) that provided adequate discrimination for distinguishing between men with ED and those without ED. Furthermore, a logistic regression model indicated that for every 1-point increase in a subject's IIEF-5 score, the odds of having ED (relative to not having ED) decreased by about half (odds ratio 0.48; 95% con®dence interval (CI), 0.42±0.54).
The CART analysis indicated that a score of 21 was the optimal cutoff score for determining whether or not a subject had ED. Men who scored 21 were retrospectively classi®ed as having had ED, whereas men who scored b 21 were retrospectively classi®ed as not having had ED. Table 4 contains the diagnostic statistics for the sample data and the cross-validation, which were identical in this case, for an optimal cutoff point of 21.
The corresponding sensitivity was 0.98 (that is, 1018 men predicted to have ED out of 1036 men clinically diagnosed with ED) and the speci®city was 0.88 (that is, 102 men predicted not to have ED out of 116 controls). Thus, for men who had ED, 98% of them were classi®ed correctly by the IIEF-5 as having had ED; for men who did not have ED, 88% of them were classi®ed correctly by the IIEF-5 as not having had ED. These rates, coupled with an estimated clinical rate of ED of 50%, suggest that there was an 89% chance that a subject actually had ED given that he was diagnosed as much based on his IIEF-5 score (that is, 0.89 is the positive predictive value). There was about a 98% chance that a subject did not actually have ED given that he was diagnosed as not having had ED based on his IIEF-5 score (that is, 0.98 is the negative predictive value). The estimated kappa coef®cient of 0.85 indicated substantial agreement, above and beyond Figure 1 Receiver operating characteristic curve for the IIEF-5. a Men with a IIEF-5 score less than or equal to a given cutoff score were retrospectively classi®ed as having had ED, whereas men with scores greater than the same cutoff were retrospectively classi®ed as not having had ED. IIEF-5 scores can range from 5 to 25. Probabilities are rounded. b The true-positive rate, or sensitivity, is the proportion of men with ED who were classi®ed correctly as having had ED. c The false-positive rate, or 1 minus the speci®city, is the proportion of men without ED who were classi®ed incorrectly as having had ED. d This is the (unconditional) probability of ED for men with scores less than a given cutoff score, where lower scores suggest more ED. Abridged version of IIEF-5 RC Rosen et al chance, between clinical diagnosis and predicted diagnosis.
Classifying severity of erectile dysfunction
Step 1. Based on the criteria outlined in the Methods section, Item 3 of the IIEFÐfrequency of penetration for sexual intercourseÐ was selected as the proxy measure for severity of ED. Men who responded with a 1 (almost never/never), 2 (a few times (much less than half the time)), 3 (sometimes (about half the time)), or 4 (most times (much more than half the time)) concerning how often they were able to penetrate or enter their partner were classi®ed as having ED, whereas those who responded with a category code of 5 (almost always/ always) were classi®ed as not having ED.
Step 2. Response categories for Item 3 of the IIEF were best related to the IIEF-5 scores as follows: the response`almost never/never' of Item 3 corresponded to an IIEF-5 score between 5 and 7 (inclusive),`a few times' to a score between 8 and 11,`sometimes' to a score between 12 and 16,`most times' to a score between 17 and 21, and`almost always/always' to a score between 22 and 25. This last category was predetermined from the previous analysis that indicated that a score above 21 suggested no ED. Thus, ED severity was classi®ed into the following ®ve categories based on IIEF-5 scores; severe (5±7), moderate (8±11), mild to moderate (12±16), mild (17±21), and no ED (22± 25). These categories were based on our clinical understanding of the scores.
Step 3. each of the ten pairs of ®ve category means was compared and was signi®cantly different according to Scheffe's 95% con®dence intervals. Table 5 provides the number of men classi®ed bỳ true' grade and predictive grade of ED severity. A total of 968 men gave complete and non-zero responses to Item 3 on the IIEF and to the ®ve items on the IIEF-5. Men tended to be classi®ed correctly into their`true' level of ED more often than any other level. An exception was men with a`true' mild level of ED; they were classi®ed most frequently into the predictive grade of`mild to moderate.' Men who were misclassi®ed tended to be assigned into a degree category immediately adjacent to the`correct' category, rather than into a more remote category. Substantial overall agreement between`true' and predictive grades was found; the weighted kappa value was 0.82 (95% CI, 0.80±0.85). The Spearman and Kendall (tau-b) rank-order correlations between these grades, respectively, were 0.79 (95% CI, 0.76± 0.82) and 0.72 (95% CI, 0.69±0.75), suggesting a high association.
Discussion
The 15 items of the IIEF can be segregated into ®ve sexual function domains: erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction. 9 It is not surprising that four of the ®ve items on the IIEF-5 were taken from the sixitem erectile function domain, which has the strongest psychometric properties of the ®ve domains the IIEF 9 and can itself serve as a complementary diagnostic measure. 16, 17 But this ®nding could not have been ascertained unless the current investigation was undertaken. Of the ®ve items on the IIEF-5, only Item 7 (intercourse satisfaction) is not a member of the erectile function domain. Hence, the results of this report also lend support for items in the erectile function domain as an additional diagnostic tool. Moreover, the diagnostic results between the erectile function domain and the IIEF-5 are nearly identical (data not shown). Severe  224  54  10  0  0  288  Moderate  50  134  57  5  0  246  Mild to moderate  17  56  98  15  0  186  Mild  3  32  63  44  3  145  No ED  0  0  0  3  100  103  Total  294  276  228  67  103  968 a As speci®ed in the text, a`true' grading was based on a category of penetration ability (item 3) of the IIEF, whereas a predictive grading was based on a given range of IIEF-5 scores as speci®ed in the text. ED erectile dysfunction.
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There are a few methodologic differences, however, between these two diagnostic tools. The inclusion of Item 7 on sexual intercourse satisfaction is a distinguishing feature of the IIEF-5 that is absent from the erectile function domain. Intercourse satisfaction gives a high level of discrimination and addresses a central element in the NIH de®nition of ED. 10 Item 7 was used to establish a gradient of ED severity for the erectile function domain, whereas penetration ability (Item 3) served this key role for the IIEF-5. The IIEF-5 has only ®ve items, whereas the erectile function domain has six items; this may or may not increase the number of completed responses in clinical settings but is unlikely to reduce it. Finally, items in the IIEF-5 are phrased to reference the prior six-month period, which conforms with the NIH's current reference period for establishing a diagnosis of ED. In contrast, items in the erectile function domain have a reference period of four weeks.
The ROC curve provides evidence that the IIEF-5 can be an excellent diagnostic test. Although several cutoff scores may be acceptable (see Table 3 ), the cutoff score of 21 is optimal because it possesses the best discriminatory diagnostic properties and is based on a reasonable assumption that, in a clinical setting, misclassifying a subject with ED is as serious as misclassifying a subject without ED. This assumption, which is an important consideration in a clinical population, neutralizes the classi®cation process and removes the subjectivity of quantifying and favoring one type of misclassi®cation over the other, which may vary from clinician to clinician. Nonetheless, further research would be useful to extend the primary diagnostic analysis by determining optimal cutoff scores for different prevalence rates of ED and unequal misclassi®cation rates. Research along these lines may expand the utility of the IIEF-5 by increasing the precision of diagnostic cutoffs for clinical subpopulations with varying levels of risk for ED and developing its use as an epidemiologic instrument to estimate prevalence rates of ED in these subgroups.
The evaluation of the IIEF-5 was retrospective because the clinical diagnosis of whether or not a subject had ED was determined before, rather than after, consideration of his score. The evaluation was based on ®ve items that were part of a larger pool of 15 items that were all completed together; responses to the ®ve items were not evaluated in isolation but in tandem with the other ten items on the IIEF. Moreover, the current NIH guidelines recommend using six months, instead of the four weeks used in this investigation, as the reference period for answering questions on ED. The best way to ascertain the impact of these modi®cations would be to incorporate them into a prospective study for validation. A similar type of validation approach was adopted when a diagnostic aid was ®rst evaluated retrospectively for predicting myocardial infarction in patients arriving at the emergency room with acute chest pain. 18 Further prospective research led to validation of the same diagnostic instrument. 19 Thus, as a further evaluation of the utility of the IIEF-5 as a diagnostic tool, a number of prospective US and European studies of ED will adopt this measure.
Additional research is needed on the validity of our proposed severity classi®cation for ED. This research should include a validation study that assesses the degree of agreement and magnitude of correlation between subject self-assessment of erectile function and the IIEF-5 with respect to levels of ED severity. Further research is also needed on the relationship between ED severity and subjective distress or quality of life effects in different patient groups. 6 The current study was limited to the assessment of erectile function and intercourse satisfaction. Further studies are underway on the relationship of these variables to patient quality of life.
The diagnostic evaluation of the IIEF-5 was based only on men who reported having attempted sexual intercourse in the four-week period before ®lling out the questionnaire (that is, those men with non-zero coded responses). When men who reported not having attempted sexual intercourse are included in the classi®cation of severity, resulting in a total of 979 subjects, the same level of overall agreement between predicted and`true' levels of ED was obtained (weighted kappa 0.82). If men who reported having had no sexual activity are considered, we suggest that the severest category of ED be graded from 1 to 7, instead of 5 to 7, provided that they had clinically diagnosed ED or were involved in a stable relationship with a female partner.
With the advent of recently available oral therapeutics for the treatment of ED, 20, 21 the need for accurate diagnoses within worldwide subpopulations of men is greater than ever. The IIEF-5 is intended to complement, not supplant, clinical judgment and useful diagnostic assessments. It may be particularly useful as an initial screening instrument in a general practice setting. One company (P®zer), for instance, has used it as a Sexual Health Inventory for Men. Because of its simplicity and the favorable diagnostic properties reported here, the IIEF-5 could aid in decreasing the incorrect diagnosis of ED and decreasing the number of undiagnosed cases of ED worldwide.
are used from Viagra1 clinical trials, all analyses, results, and conclusions are based on pre-treatment (baseline) data and did not involve any treatment intervention.
